MIA and Miyoshi myopathy: Additionally, in relation to the findings from this study, the efficacy of MM treatment could possibly be further upgraded in some groups of clinical patients undergoing immunotherapy by utilizing the same Anti-MIA Ab as a molecular target and observing its treatment outcomes [4].